The global multiplex assays market grew from $1,959.3 million in 2016 to $3,016.5 million in 2021 at a compound annual growth rate (CAGR) of 9.0%. The market is expected to grow from $3,016.5 million in 2021 to $4,365.4 million in 2026 at a CAGR of 7.7%, and to $6,312.6 million in 2031 at a CAGR of 7.7%.
Growth in the historic period resulted from the increased healthcare expenditure, emerging markets growth, rapid technological advances and a rapid growth in aging population.
Going forward, the rise in funding, government initiatives for genetic and microbiological research, aging population, increasing prevalence of chronic diseases and a rapid rise in various bacterial and viral epidemics will drive the market growth. Factors that could hinder the growth of the multiplex assays market in the future include a lack of skilled/trained labor and insufficient and outdated health systems in underdeveloped and developing countries.
The multiplex assays market is segmented by type into protein-based multiplex assays, nucleic acid-based multiplex assays and other types. The protein-based multiplex assays market was the largest segment of the multiplex assays market segmented by type, accounting for 60.3% of the total in 2021. Going forward, the nucleic acid-based multiplex assays market is expected to be the fastest growing segment in the multiplex assays market segmented by type, at a CAGR of 8.1% during 2021-2026.
The multiplex assays market is also segmented by identification technology into flow cytometry, multiplex real-time PCR (polymerase chain reaction) and other identification technologies. The flow cytometry market was the largest segment of the multiplex assays market segmented by identification technology, accounting for 55.0% of the total in 2021. Going forward, the multiplex real-time PCR market is expected to be the fastest growing segment in the multiplex assays market segmented by identification technology, at a CAGR of 7.8% during 2021-2026.
The multiplex assays market is also segmented by detection technology into enzyme-linked immunosorbent assay (ELISA), luminescence, fluorescence and other detection technologies. The enzyme-linked immunosorbent assay (ELISA)market was the largest segment of the multiplex assays market segmented by detection technology, accounting for 45.3% of the total in 2021. Going forward, the enzyme-linked immunosorbent assay (ELISA) market is expected to be the fastest growing segment in the multiplex assays market segmented by detection technology, at a CAGR of 7.9% during 2021-2026.
The multiplex assays market is also segmented by application into research and development and clinical diagnostics. The research and development market was the largest segment of the multiplex assays market segmented by application, accounting for 60.7% of the total in 2021. Going forward, the clinical diagnostics market is expected to be the fastest growing segment in the multiplex assays market segmented by application, at a CAGR of 7.7% during 2021-2026.
The multiplex assays market is also segmented by end-user into pharmaceutical and biotechnology companies, hospitals and research institutes, reference laboratories and other end-users. The pharmaceutical and biotechnology companies market was the largest segment of the multiplex assays market segmented by end-user, accounting for 45.3% of the total in 2021. Going forward, the hospitals and research institutes market is expected to be the fastest growing segment in the multiplex assays market segmented by end-user, at a CAGR of 8.0% during 2021-2026.
North America was the largest region in the multiplex assays market, accounting for 34.8% of the total in 2021. It was followed by Asia-Pacific, and then the other regions. Going forward, the fastest-growing regions in the multiplex assays market will be Asia-Pacific and North America, where growth will be at CAGRs of 8.3% and 8.0% respectively. These will be followed by Western Europe and South America, where the markets are expected to grow at CAGRs of 7.4% and 7.0% respectively.
The global multiplex assays market is slightly concentrated, with a few large players. The top ten competitors in the market made up to 33.16% of the total market in 2021. Seegene Inc was the largest competitor with 8.29% share of the market, followed by DiaSorin SpA with 6.97%, Thermo Fisher Scientific Inc with 3.75%, Bio-Rad Laboratories Inc with 3.25%, Qiagen NV with 2.57%, Abcam Plc with 2.46%, PerkinElmer Inc with 2.22%, Hologic Corporation with 1.46%, Meso Scale Diagnostics with 1.30% and Merck KGaA with 0.90%.
The top growth potential in the multiplex assays market by type will arise in the protein-based multiplex assays segment, which will gain $822.6 million of global annual sales by 2026. The top growth potential in the multiplex assays market by identification technology will arise in the flow cytometry segment, which will gain $742.0 million of global annual sales by 2026. The top growth potential in the multiplex assays market by detection technology will arise in the enzyme-linked immunosorbent assay (ELISA) segment, which will gain $630.5 million of global annual sales by 2026. The top growth potential in the multiplex assays market by application will arise in the research and development segment, which will gain $816.8 million of global annual sales by 2026. The top growth potential in the multiplex assays market by end-user will arise in the pharmaceutical and biotechnology companies segment, which will gain $628.4 million of global annual sales by 2026. The multiplex assays market size will gain the most in the USA at $471.0 million.
Market-trend-based strategies for the multiplex assays market include focus on automated molecular diagnostics platforms, focus on launch of innovative tests, focus on development of new COVID-19 test kits, focus on launch of new assays with enhanced software, focus on new product launches and focus on strategic partnerships and collaborations.
Player-adopted strategies in the multiplex assays market include focus on providing innovative solutions through new product launches, focus on strengthening business operations through mergers and acquisitions and focus on enhancing businesses operations through securing new regulatory approvals.
To take advantage of the opportunities, the publisher recommends the companies in the multiplex assays market to focus on automated molecular diagnostics platforms, focus on launch of innovative tests, focus on development of new COVID-19 test kits, focus on new product launches, expand in emerging markets, continue to focus on developed markets, focus on strategic partnerships and collaborations, offer competitive pricing, participate in trade shows and events and continue to focus on fast-growing end-users.
This report describes and explains the multiplex assays market and covers 2016-2021, termed the historic period, and 2021-2026 termed the forecast period, along with further forecasts for the period 2026-2031. The report evaluates the market across each region and for the major economies within each region.
Growth in the historic period resulted from the increased healthcare expenditure, emerging markets growth, rapid technological advances and a rapid growth in aging population.
Going forward, the rise in funding, government initiatives for genetic and microbiological research, aging population, increasing prevalence of chronic diseases and a rapid rise in various bacterial and viral epidemics will drive the market growth. Factors that could hinder the growth of the multiplex assays market in the future include a lack of skilled/trained labor and insufficient and outdated health systems in underdeveloped and developing countries.
The multiplex assays market is segmented by type into protein-based multiplex assays, nucleic acid-based multiplex assays and other types. The protein-based multiplex assays market was the largest segment of the multiplex assays market segmented by type, accounting for 60.3% of the total in 2021. Going forward, the nucleic acid-based multiplex assays market is expected to be the fastest growing segment in the multiplex assays market segmented by type, at a CAGR of 8.1% during 2021-2026.
The multiplex assays market is also segmented by identification technology into flow cytometry, multiplex real-time PCR (polymerase chain reaction) and other identification technologies. The flow cytometry market was the largest segment of the multiplex assays market segmented by identification technology, accounting for 55.0% of the total in 2021. Going forward, the multiplex real-time PCR market is expected to be the fastest growing segment in the multiplex assays market segmented by identification technology, at a CAGR of 7.8% during 2021-2026.
The multiplex assays market is also segmented by detection technology into enzyme-linked immunosorbent assay (ELISA), luminescence, fluorescence and other detection technologies. The enzyme-linked immunosorbent assay (ELISA)market was the largest segment of the multiplex assays market segmented by detection technology, accounting for 45.3% of the total in 2021. Going forward, the enzyme-linked immunosorbent assay (ELISA) market is expected to be the fastest growing segment in the multiplex assays market segmented by detection technology, at a CAGR of 7.9% during 2021-2026.
The multiplex assays market is also segmented by application into research and development and clinical diagnostics. The research and development market was the largest segment of the multiplex assays market segmented by application, accounting for 60.7% of the total in 2021. Going forward, the clinical diagnostics market is expected to be the fastest growing segment in the multiplex assays market segmented by application, at a CAGR of 7.7% during 2021-2026.
The multiplex assays market is also segmented by end-user into pharmaceutical and biotechnology companies, hospitals and research institutes, reference laboratories and other end-users. The pharmaceutical and biotechnology companies market was the largest segment of the multiplex assays market segmented by end-user, accounting for 45.3% of the total in 2021. Going forward, the hospitals and research institutes market is expected to be the fastest growing segment in the multiplex assays market segmented by end-user, at a CAGR of 8.0% during 2021-2026.
North America was the largest region in the multiplex assays market, accounting for 34.8% of the total in 2021. It was followed by Asia-Pacific, and then the other regions. Going forward, the fastest-growing regions in the multiplex assays market will be Asia-Pacific and North America, where growth will be at CAGRs of 8.3% and 8.0% respectively. These will be followed by Western Europe and South America, where the markets are expected to grow at CAGRs of 7.4% and 7.0% respectively.
The global multiplex assays market is slightly concentrated, with a few large players. The top ten competitors in the market made up to 33.16% of the total market in 2021. Seegene Inc was the largest competitor with 8.29% share of the market, followed by DiaSorin SpA with 6.97%, Thermo Fisher Scientific Inc with 3.75%, Bio-Rad Laboratories Inc with 3.25%, Qiagen NV with 2.57%, Abcam Plc with 2.46%, PerkinElmer Inc with 2.22%, Hologic Corporation with 1.46%, Meso Scale Diagnostics with 1.30% and Merck KGaA with 0.90%.
The top growth potential in the multiplex assays market by type will arise in the protein-based multiplex assays segment, which will gain $822.6 million of global annual sales by 2026. The top growth potential in the multiplex assays market by identification technology will arise in the flow cytometry segment, which will gain $742.0 million of global annual sales by 2026. The top growth potential in the multiplex assays market by detection technology will arise in the enzyme-linked immunosorbent assay (ELISA) segment, which will gain $630.5 million of global annual sales by 2026. The top growth potential in the multiplex assays market by application will arise in the research and development segment, which will gain $816.8 million of global annual sales by 2026. The top growth potential in the multiplex assays market by end-user will arise in the pharmaceutical and biotechnology companies segment, which will gain $628.4 million of global annual sales by 2026. The multiplex assays market size will gain the most in the USA at $471.0 million.
Market-trend-based strategies for the multiplex assays market include focus on automated molecular diagnostics platforms, focus on launch of innovative tests, focus on development of new COVID-19 test kits, focus on launch of new assays with enhanced software, focus on new product launches and focus on strategic partnerships and collaborations.
Player-adopted strategies in the multiplex assays market include focus on providing innovative solutions through new product launches, focus on strengthening business operations through mergers and acquisitions and focus on enhancing businesses operations through securing new regulatory approvals.
To take advantage of the opportunities, the publisher recommends the companies in the multiplex assays market to focus on automated molecular diagnostics platforms, focus on launch of innovative tests, focus on development of new COVID-19 test kits, focus on new product launches, expand in emerging markets, continue to focus on developed markets, focus on strategic partnerships and collaborations, offer competitive pricing, participate in trade shows and events and continue to focus on fast-growing end-users.
This report describes and explains the multiplex assays market and covers 2016-2021, termed the historic period, and 2021-2026 termed the forecast period, along with further forecasts for the period 2026-2031. The report evaluates the market across each region and for the major economies within each region.
Table of Contents
1. Executive Summary2. Table of Contents
3. List of Figures
4. List of Tables
5. Report Structure
6. Introduction and Market Characteristics
6.1. General Market Definition
6.2. Summary
6.3. Multiplex Assays Market Definition and Segmentations
6.4. Market Segmentation By Type
6.4.1. Protein-Based Multiplex Assays
6.4.2. Nucleic Acid-Based Multiplex Assays
6.4.3. Other Types
6.5. Market Segmentation By Identification Technology
6.5.1. Flow Cytometry
6.5.2. Multiplex Real-Time PCR
6.5.3. Other Identification Technologies
6.6. Market Segmentation By Detection Technology
6.6.1. Enzyme-Linked Immunosorbent Assay (ELISA)
6.6.2. Luminescence
6.6.3. Fluorescence
6.6.4. Other Detection Technologies
6.7. Market Segmentation By Application
6.7.1. Research And Development
6.7.2. Clinical Diagnostics
6.8. Market Segmentation By End-User
6.8.1. Pharmaceutical And Biotechnology Companies
6.8.2. Hospitals And Research Institutes
6.8.3. Reference Laboratories
6.8.4. Other End-Users
7. Major Market Trends
7.1. Automated Molecular Diagnostics Platforms
7.2. Launch Of Innovative Tests
7.3. Development Of New COVID-19 Test Kits
7.4. Launch Of New Assays With Enhanced Software
7.5. New Product Launches
7.6. Strategic Partnerships And Collaborations
8. Global Market Size And Growth
8.1. Market Size
8.2. Historic Market Growth, 2016 - 2021, Value ($ Million)
8.2.1. Market Drivers 2016 - 2021
8.2.2. Market Restraints 2016 - 2021
8.3. Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
8.3.1. Market Drivers 2021 - 2026
8.3.2. Market Restraints 2021 - 2026
9. Global Market Segmentation
9.1. Global Multiplex Assays Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
9.2. Global Multiplex Assays Market, Segmentation By Identification Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
9.3. Global Multiplex Assays Market, Segmentation By Detection Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
9.4. Global Multiplex Assays Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
9.5. Global Multiplex Assays Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
9.5.1. Global Clinical Diagnostics Market, By Disease, Historic and Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
10. Global Market, Regional And Country Analysis
10.1. Global Multiplex Assays Market, By Region, Historic and Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
10.2. Global Multiplex Assays Market, By Country, Historic and Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11. Asia-Pacific Market
11.1. Summary
11.2. Market Overview
11.2.1. Region Information
11.2.2. Market Information
11.2.3. Background Information
11.2.4. Government Initiatives
11.2.5. Regulations
11.2.6. Regulatory Bodies
11.2.7. Major Associations
11.2.8. Taxes Levied
11.2.9. Corporate Tax Structure
11.2.10. Investments
11.2.11. Major Companies
11.3. Asia-Pacific Multiplex Assays Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.4. Asia-Pacific Multiplex Assays Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.5. Asia-Pacific Multiplex Assays Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.6. Asia-Pacific Multiplex Assays Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.7. Asia-Pacific Multiplex Assays Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.8. Asia Pacific Multiplex Assays Market: Country Analysis
11.9. China Market
11.10. Summary
11.11. Market Overview
11.11.1. Country Information
11.11.2. Market Information
11.11.3. Background Information
11.11.4. Government Initiatives
11.11.5. Regulations
11.11.6. Regulatory Bodies
11.11.7. Major Associations
11.11.8. Taxes Levied
11.11.9. Corporate Tax Structure
11.11.10. Investments
11.11.11. Major Companies
11.12. China Multiplex Assays Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.13. China Multiplex Assays Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.14. China Multiplex Assays Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.15. China Multiplex Assays Market, Segmentation By End User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.16. China Multiplex Assays Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.17. India Market
11.18. India Multiplex Assays Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.19. India Multiplex Assays Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.20. India Multiplex Assays Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.21. India Multiplex Assays Market, Segmentation By End User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.22. India Multiplex Assays Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.23. Japan Market
11.24. Japan Multiplex Assays Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.25. Japan Multiplex Assays Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.26. Japan Multiplex Assays Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.27. Japan Multiplex Assays Market, Segmentation By End User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.28. Japan Multiplex Assays Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.29. Australia Market
11.30. Australia Multiplex Assays Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.31. Australia Multiplex Assays Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.32. Australia Multiplex Assays Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.33. Australia Multiplex Assays Market, Segmentation By End User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.34. Australia Multiplex Assays Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.35. Indonesia Market
11.36. Indonesia Multiplex Assays Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.37. Indonesia Multiplex Assays Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.38. Indonesia Multiplex Assays Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.39. Indonesia Multiplex Assays Market, Segmentation By End User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.40. Indonesia Multiplex Assays Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.41. South Korea Market
11.42. South Korea Multiplex Assays Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.43. South Korea Multiplex Assays Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.44. South Korea Multiplex Assays Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.45. South Korea Multiplex Assays Market, Segmentation By End User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.46. South Korea Multiplex Assays Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12. Western Europe Market
12.1. Summary
12.2. Market Overview
12.2.1. Region Information
12.2.2. Market Information
12.2.3. Background Information
12.2.4. Government Initiatives
12.2.5. Regulations
12.2.6. Regulatory Bodies
12.2.7. Major Associations
12.2.8. Taxes Levied
12.2.9. Corporate Tax Structure
12.2.10. Investments
12.2.11. Major Companies
12.3. Western Europe Multiplex Assays Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
12.4. Western Europe Multiplex Assays Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
12.5. Western Europe Multiplex Assays Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.6. Western Europe Multiplex Assays Market, Segmentation By End User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.7. Western Europe Multiplex Assays Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.8. Western Europe Multiplex Assays Market: Country Analysis
12.9. UK Market
12.10. UK Multiplex Assays Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
12.11. UK Multiplex Assays Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
12.12. UK Multiplex Assays Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.13. UK Multiplex Assays Market, Segmentation By End User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.14. UK Multiplex Assays Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.15. Germany Market
12.16. Germany Multiplex Assays Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
12.17. Germany Multiplex Assays Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
12.18. Germany Multiplex Assays Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.19. Germany Multiplex Assays Market, Segmentation By End User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.20. Germany Multiplex Assays Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.21. France Market
12.22. France Multiplex Assays Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
12.23. France Multiplex Assays Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
12.24. France Multiplex Assays Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.25. France Multiplex Assays Market, Segmentation By End User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.26. France Multiplex Assays Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13. Eastern Europe Market
13.1. Summary
13.2. Market Overview
13.2.1. Region Information
13.2.2. Market Information
13.2.3. Background Information
13.2.4. Government Initiatives
13.2.5. Regulations
13.2.6. Regulatory Bodies
13.2.7. Major Associations
13.2.8. Taxes Levied
13.2.9. Corporate Tax Structure
13.2.10. Investments
13.2.11. Major Companies
13.3. Eastern Europe Multiplex Assays Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.4. Eastern Europe Multiplex Assays Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.5. Eastern Europe Multiplex Assays Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.6. Eastern Europe Multiplex Assays Market, Segmentation By End User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.7. Eastern Europe Multiplex Assays Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.8. Eastern Europe Multiplex Assays Market: Country Analysis
13.9. Russia Market
13.10. Russia Multiplex Assays Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.11. Russia Multiplex Assays Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.12. Russia Multiplex Assays Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.13. Russia Multiplex Assays Market, Segmentation By End User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.14. Russia Multiplex Assays Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14. North America Market
14.1. Summary
14.2. Market Overview
14.2.1. Region Information
14.2.2. Market Information
14.2.3. Background Information
14.2.4. Government Initiatives
14.2.5. Regulations
14.2.6. Regulatory Bodies
14.2.7. Major Associations
14.2.8. Taxes levied
14.2.9. Corporate Tax Structure
14.2.10. Investments
14.2.11. Major Companies
14.3. North America Multiplex Assays Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
14.4. North America Multiplex Assays Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
14.5. North America Multiplex Assays Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.6. North America Multiplex Assays Market, Segmentation By End User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.7. North America Multiplex Assays Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.8. North America Multiplex Assays Market: Country Analysis
14.9. USA Market
14.10. Summary
14.11. Market Overview
14.11.1. Country Information
14.11.2. Market Information
14.11.3. Background Information
14.11.4. Government Initiatives
14.11.5. Regulations
14.11.6. Regulatory Bodies
14.11.7. Major Associations
14.11.8. Taxes Levied
14.11.9. Corporate Tax Structure
14.11.10. Investments
14.11.11. Major Companies
14.12. USA Multiplex Assays Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
14.13. USA Multiplex Assays Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
14.14. USA Multiplex Assays Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.15. USA Multiplex Assays Market, Segmentation By End User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.16. USA Multiplex Assays Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15. South America Market
15.1. Summary
15.2. Market Overview
15.2.1. Region Information
15.2.2. Market Information
15.2.3. Background Information
15.2.4. Government Initiatives
15.2.5. Regulations
15.2.6. Regulatory Bodies
15.2.7. Major Associations
15.2.8. Taxes Levied
15.2.9. Corporate Tax Structure
15.2.10. Investments
15.2.11. Major Companies
15.3. South America Multiplex Assays Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
15.4. South America Multiplex Assays Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
15.5. South America Multiplex Assays Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.6. South America Multiplex Assays Market, Segmentation By End User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.7. South America Multiplex Assays Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.8. South America Multiplex Assays Market: Country Analysis
15.9. Brazil Market
15.10. Brazil Multiplex Assays Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
15.11. Brazil Multiplex Assays Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
15.12. Brazil Multiplex Assays Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.13. Brazil Multiplex Assays Market, Segmentation By End User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.14. Brazil Multiplex Assays Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
16. Middle East Market
16.1. Summary
16.2. Market Overview
16.2.1. Region Information
16.2.2. Market Information
16.2.3. Background Information
16.2.4. Government Initiatives
16.2.5. Regulations
16.2.6. Regulatory Bodies
16.2.7. Major Associations
16.2.8. Taxes Levied
16.2.9. Corporate Tax Structure
16.2.10. Investments
16.2.11. Major Companies
16.3. Middle East Multiplex Assays Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
16.4. Middle East Multiplex Assays Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
16.5. Middle East Multiplex Assays Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
16.6. Middle East Multiplex Assays Market, Segmentation By End User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
16.7. Middle East Multiplex Assays Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
17. Africa Market
17.1. Summary
17.2. Market Overview
17.2.1. Region Information
17.2.2. Market Information
17.2.3. Background Information
17.2.4. Government Initiatives
17.2.5. Regulations
17.2.6. Regulatory Bodies
17.2.7. Major Associations
17.2.8. Taxes Levied
17.2.9. Corporate Tax Structure
17.2.10. Investments
17.2.11. Major Companies
17.3. Africa Multiplex Assays Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
17.4. Africa Multiplex Assays Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
17.5. Africa Multiplex Assays Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
17.6. Africa Multiplex Assays Market, Segmentation By End User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
17.7. Africa Multiplex Assays Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
18. Competitive Landscape and Company Profiles
19. Company Profiles
19.1. Seegene Inc
19.1.1. Company Overview
19.1.2. Products And Services
19.1.3. Business Strategy
19.1.4. Financial Overview
19.2. DiaSorin SpA
19.2.1. Company Overview
19.2.2. Products And Services
19.2.3. Business Strategy
19.2.4. Financial Overview
19.3. Thermo Fisher Scientific Inc
19.3.1. Company Overview
19.3.2. Products And Services
19.3.3. Business Strategy
19.3.4. Financial Overview
19.4. Bio-Rad Laboratories Inc
19.4.1. Company Overview
19.4.2. Products And Services
19.4.3. Business Strategy
19.4.4. Financial Overview
19.5. Qiagen NV
19.5.1. Company Overview
19.5.2. Products And Services
19.5.3. Business Strategy
19.5.4. Financial Overview
20. Key Mergers And Acquisitions
20.1. CellCarta Acquired Commercial Rights To The Antibody Panels And Assays From Precision Assays
20.2. Univercells Technologies Acquired SynHelix
20.3. Roche Acquired TIB Molbiol
20.4. Becton, Dickinson And Company Acquired Scanwell Health
20.5. Mylab Discovery Solutions Partnered With Hemex Health
20.6. Illumina Acquired GRAIL
20.7. XPhyto Therapeutics Acquired 3a Diagnostics
20.8. Roche Acquired GenMark
20.9. Danaher Acquired Swift Biosciences
20.10. Thermo Fisher Scientific Acquired Mesa Biotech
20.11. Merck Acquired AmpTec
20.12. Abcam Acquired Expedeon
20.13. Tulip Diagnostics Acquired Biosense Technologies
20.14. Edan Diagnostics, Inc. Acquired Molecular Diagnostics
20.15. Siemens Healthineers AG Acquired Minicare BV
21. Opportunities And Strategies
21.1. Global Multiplex Assays Market In 2026 - Countries Offering Most New Opportunities
21.2. Global Multiplex Assays Market In 2026 - Segments Offering Most New Opportunities
21.3. Global Multiplex Assays Market In 2026 - Growth Strategies
21.3.1. Market Trend Based Strategies
21.3.2. Competitor Strategies
22. Multiplex Assays Market, Conclusions And Recommendations
22.1. Conclusions
22.2. Recommendations
22.2.1. Product
22.2.2. Place
22.2.3. Price
22.2.4. Promotion
22.2.5. People
23. Appendix
23.1. Market Data Sources
23.2. Research Methodology
23.3. Currencies
23.4. About the Publisher
23.5. Copyright and Disclaimer
Executive Summary
Multiplex Assays Global Market Opportunities And Strategies To 2031 provides the strategists; marketers and senior management with the critical information they need to assess the global multiplex assays market as it emerges from the COVID-19 shut down.Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider multiplex assays market; and compares it with other markets.
The report covers the following chapters:
Introduction and Market CharacteristicsBrief introduction to the segmentations covered in the market, definitions and explanations about the multiplex assays market.
Key Trends
Highlights the major trends shaping the global multiplex assays market. This section also highlights likely future developments in the market.
Global Market Size and Growth
Global historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
- Regional And Country Analysis
Market Segmentation
Contains the market values (2016-2031) and analysis for segment by type, by identification technology, by detection technology, by application and by end-user in the market.
Regional Market Size and Growth
Regional market size (2021), historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape
Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Key Mergers and Acquisitions
Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
Market Opportunities And Strategies
Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations
This section Includes recommendations for multiplex assays providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
Appendix
This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Scope
Markets Covered
1) By Type: Protein-Based Multiplex Assays; Nucleic Acid-Based Multiplex Assays; Other Types2) By Identification Technology: Flow Cytometry; Multiplex Real-Time PCR; Other Identification Technologies
3) By Detection Technology: Enzyme-Linked Immunosorbent Assay (ELISA); Luminescence; Fluorescence; Other Detection Technologies
4) By Application: Research And Development; Clinical Diagnostics
5) By End User: Pharmaceutical And Biotechnology Companies; Hospitals And Research Institutes; Reference Laboratories; Other End-Users
Companies Mentioned: Seegene Inc; DiaSorin SpA; Thermo Fisher Scientific Inc; Bio-Rad Laboratories Inc; Qiagen NV
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; multiplex assays indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Seegene Inc.
- DiaSorin SpA
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories Inc.
- Qiagen NV
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 320 |
| Published | January 2023 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 3016.5 Million |
| Forecasted Market Value ( USD | $ 6312.6 Million |
| Compound Annual Growth Rate | 7.7% |
| Regions Covered | Global |
![Multiplex Assays Market by Type (Protein [Bead, Planar], Nucleic Acid, Cell) Technology (Flow Cytometry, PCR, Immunoassay) Application (R&D, Diagnosis (Oncology, Cardiovascular, Infectious, Autoimmune Diseases) Product, End User - Global Forecast to 2030 - Product Image](http://www.researchandmarkets.com/product_images/12541/12541970_60px_jpg/multiplex_assays_market.jpg)
